Inventor · disambiguated record
Hal E. Broxmeyer
Also filed as: BROXMEYER HAL E · BROXMEYER HAL EDWARD
16 granted patents·9 pending applications·1,466 citations·filing 1987–2018
96Inventor score
Files withGENZYME CORP7PHARMASTEM THERAPEUTICS INC3ANORMED INC2BIOCYTE CORP2CHRISTOPHERSON II KENT W2
Top patents by PatentIndex Score
25 records- 0197US5004681APreservation of fetal and neonatal hematopoietic stem and progenitor cells of the bloodBIOCYTE CORP·Filed 1987·Granted Apr 2, 1991·468 cites·9 claims
- 0296US5192553AIsolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic useBIOCYTE CORP·Filed 1988·Granted Mar 9, 1993·452 cites·64 claims
- 0395US7935692B2Methods to mobilize progenitor/stem cellsGENZYME CORP·Filed 2005·Granted May 3, 2011·29 cites·26 claims
- 0494US7897590B2Methods to mobilize progenitor/stem cellsGENZYME CORP·Filed 2007·Granted Mar 1, 2011·28 cites·29 claims
- 0594US6987102B2Methods to mobilize progenitor/stem cellsANORMED INC·Filed 2002·Granted Jan 17, 2006·53 cites·22 claims
- 0690US6461645B1Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the bloodPHARMASTEM THERAPEUTICS INC·Filed 1990·Granted Oct 8, 2002·133 cites·19 claims
- 0788US6605275B1Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the bloodPHARMASTEM THERAPEUTICS INC·Filed 1995·Granted Aug 12, 2003·75 cites·24 claims
- 0888US6569427B1Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the bloodPHARMASTEM THERAPEUTICS INC·Filed 1995·Granted May 27, 2003·72 cites·56 claims
- 0987US6355476B1Nucleic acid encoding MIP-1α LymphokineADVANCED RES AND TECHNOLOGYINC·Filed 1992·Granted Mar 12, 2002·85 cites·4 claims
- 1072US5149544AMethod of inhibiting progenitor cell proliferationRES CORP TECHNOLOGIES INC·Filed 1989·Granted Sep 22, 1992·27 cites·2 claims
- 1167US2019216773A1Methods to mobilize progenitor/stem cellsGENZYME CORP·Filed 2018·Application pending·0 cites
- 1266US2015246019A1Methods to mobilize progenitor/stem cellsGENZYME CORP·Filed 2014·Application pending·0 cites
- 1363US2004247574A1Methods for enhancing stem cell engraftment during transplantationFiled 2004·Application pending·0 cites
- 1463US2013273009A1Methods to mobilize progenitor/stem cellsGENZYME CORP·Filed 2013·Application pending·0 cites
- 1562US5728377AMethods and compositions incorporating IP-10UNIV TEXAS·Filed 1993·Granted Mar 17, 1998·22 cites·15 claims
- 1661US2017049747A1Methods to mobilize progenitor/stem cellsGENZYME CORP·Filed 2016·Application pending·0 cites
- 1761US2006223180A1Methods to mobilize progenitor/stem cellsANORMED INC·Filed 2006·Application pending·0 cites
- 1860US2008085264A1Methods for enhancing stem cell engraftment during transplantationCHRISTOPHERSON II KENT W·Filed 2007·Application pending·0 cites
- 1958US2011129448A1Methods to mobilize progenitor/stem cellsGENZYME CORP·Filed 2011·Application pending·0 cites
- 2050US2011091429A1Methods for Enhancing Stem Cell Engraftment During TransplantationCHRISTOPHERSON II KENT W·Filed 2010·Application pending·0 cites
- 2146US6165459AMethods for suppressing myeloid cells with chemokinesINDIANA UNIVERSITY FOUNDATION·Filed 1995·Granted Dec 26, 2000·7 cites·22 claims
- 2245US6281200B1Functional characterization of the C-C chemokine-like molecules encoded by molluscum contagiosum virus types 1 and 2ADVANCED RES & TECH INST·Filed 1998·Granted Aug 28, 2001·8 cites·21 claims
- 2343US11883435B2Compositions and methods for treating a clinical condition through the use of hematopoietic stem cellsUNIV INDIANA RES & TECH CORP·Filed 2018·Granted Jan 30, 2024·0 cites·7 claims
- 2436US6143289ACompositions of myeloid-cell-suppressive chemokinesINDIANA UNIVERSITY FOUNDATION·Filed 1992·Granted Nov 7, 2000·4 cites·22 claims
- 2533US5294544ABiologically active factorRES CORP TECHNOLOGIES INC·Filed 1992·Granted Mar 15, 1994·3 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Hal E. Broxmeyer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →